Therapeutic strategies in experimental autoimmune myasthenia gravis.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000378:metabolism / Q000532:radiotherapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use; D005260:Female; D009157:Myasthenia Gravis / Q000188:drug therapy* / Q000378:metabolism / Q000532:radiotherapy; D009469:Neuromuscular Junction / Q000378:metabolism; D051381:Rats; D011917:Rats, Inbred Lew; D011950:Receptors, Cholinergic / Q000032:analysis / Q000276:immunology
D000906:Antibodies; D011950:Receptors, Cholinergic; D003520:Cyclophosphamide; D004121:Dimethyl Sulfoxide